Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | Ordinary Shares | 409K | $6.81M | $16.65 | Jun 15, 2024 | Direct |
NexImmune, Inc. | Director | Common Stock | 2.22M | $910K | $0.41 | Mar 30, 2023 | Direct |
NexImmune, Inc. | Director | Common Stock | 1.54M | $631K | $0.41 | Mar 30, 2023 | Held by B&S NexImmune Holdco LLC |
NexImmune, Inc. | Director | Common Stock | 347K | $142K | $0.41 | Mar 30, 2023 | Held by Joshua Barer |
CONTRAFECT Corp | Director | Options (Right to Buy) | 42K | $141K | $3.35 | May 17, 2022 | Direct |
NexImmune, Inc. | Director | Stock Option (right to buy) | 45K | Jul 5, 2023 | Direct | ||
Cerecor Inc. | Director | Stock Option (Right to Buy) | 40K | Jun 15, 2021 | Direct | ||
TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | Restricted Share Units | 0 | Jun 15, 2024 | Direct |